Opko Health, Inc.
OPK
$1.31
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -11.47% | -15.71% | -14.90% | -9.75% | -7.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.47% | -15.71% | -14.90% | -9.75% | -7.31% |
| Cost of Revenue | -17.98% | -20.22% | -17.17% | -18.82% | -12.30% |
| Gross Profit | 16.75% | 9.42% | -2.87% | 57.67% | 23.03% |
| SG&A Expenses | -25.53% | -25.59% | -24.86% | -23.14% | -0.49% |
| Depreciation & Amortization | -4.45% | -5.01% | -5.74% | -5.49% | -5.65% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.26% | -17.63% | -15.72% | -16.28% | -5.46% |
| Operating Income | 35.20% | 22.58% | 17.87% | 31.30% | 0.51% |
| Income Before Tax | 47.65% | -39,513.84% | -2,225.33% | -35.34% | 37.67% |
| Income Tax Expenses | -128.25% | -141.78% | -136.68% | 31.59% | 1,664.42% |
| Earnings from Continuing Operations | 58.85% | -445.92% | -324.02% | -34.89% | 27.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.85% | -445.92% | -324.02% | -34.89% | 27.13% |
| EBIT | 35.20% | 22.58% | 17.87% | 31.30% | 0.51% |
| EBITDA | 51.72% | 31.95% | 24.18% | 43.01% | -3.74% |
| EPS Basic | 58.56% | -363.90% | -307.69% | -31.26% | 29.83% |
| Normalized Basic EPS | 2.79% | -445.90% | -412.19% | 58.94% | 23.23% |
| EPS Diluted | 59.53% | -314.98% | -272.78% | -28.20% | 28.30% |
| Normalized Diluted EPS | 6.36% | -384.00% | -360.65% | 36.75% | 20.40% |
| Average Basic Shares Outstanding | 7.98% | 12.75% | 8.17% | 2.22% | -2.62% |
| Average Diluted Shares Outstanding | -10.27% | -6.83% | -10.41% | 1.19% | 17.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |